Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.

Source:http://linkedlifedata.com/resource/pubmed/id/10722519

Download in:

View as

General Info

PMID
10722519